Greenwood Capital Associates LLC boosted its position in shares of JPMorgan International Research Enhanced Equity ETF (NYSEARCA:JIRE – Free Report) by 20.8% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 99,759 shares of the company’s stock after buying an additional 17,188 shares during the quarter. Greenwood Capital Associates LLC owned approximately 0.08% of JPMorgan International Research Enhanced Equity ETF worth $7,336,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other large investors have also added to or reduced their stakes in JIRE. HighTower Advisors LLC increased its position in shares of JPMorgan International Research Enhanced Equity ETF by 7.6% in the first quarter. HighTower Advisors LLC now owns 4,039 shares of the company’s stock valued at $257,000 after acquiring an additional 287 shares during the period. MAI Capital Management grew its stake in shares of JPMorgan International Research Enhanced Equity ETF by 1,331.6% in the first quarter. MAI Capital Management now owns 816 shares of the company’s stock worth $52,000 after purchasing an additional 759 shares during the last quarter. Royal Bank of Canada increased its holdings in JPMorgan International Research Enhanced Equity ETF by 80.6% during the 1st quarter. Royal Bank of Canada now owns 248,306 shares of the company’s stock valued at $15,820,000 after purchasing an additional 110,827 shares during the period. Goldman Sachs Group Inc. bought a new position in JPMorgan International Research Enhanced Equity ETF during the 1st quarter valued at approximately $1,265,000. Finally, Geneos Wealth Management Inc. raised its position in JPMorgan International Research Enhanced Equity ETF by 124.8% during the 1st quarter. Geneos Wealth Management Inc. now owns 25,352 shares of the company’s stock valued at $1,615,000 after purchasing an additional 14,072 shares during the last quarter.
JPMorgan International Research Enhanced Equity ETF Stock Performance
Shares of JIRE stock opened at $75.36 on Friday. JPMorgan International Research Enhanced Equity ETF has a fifty-two week low of $56.30 and a fifty-two week high of $76.77. The firm has a market cap of $9.14 billion, a P/E ratio of 16.04 and a beta of 0.82. The business’s 50 day moving average price is $74.72 and its 200-day moving average price is $72.77.
About JPMorgan International Research Enhanced Equity ETF
The JPMorgan International Research Enhanced Equity ETF (JIRE) is an exchange-traded fund that mostly invests in total market equity. The fund is an actively managed ETF that provides exposure to stocks of any market capitalization from developed markets, excluding North America. JIRE was launched on Jun 10, 2022 and is managed by JPMorgan Chase.
Featured Stories
- Five stocks we like better than JPMorgan International Research Enhanced Equity ETF
- Do not delete, read immediately
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- Can Any Expenses Be Deducted From Capital Gains Tax?
- Do you know what Amazon is planning for January 1?
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Want to see what other hedge funds are holding JIRE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for JPMorgan International Research Enhanced Equity ETF (NYSEARCA:JIRE – Free Report).
Receive News & Ratings for JPMorgan International Research Enhanced Equity ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JPMorgan International Research Enhanced Equity ETF and related companies with MarketBeat.com's FREE daily email newsletter.
